CIK 0001778922
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SpyGlass Pharma, Inc.
Sign in to watch- Ticker
- SGP
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833044245
- Phone
- +1 949-284-6904
- Business address
- 15326 ALTON PARKWAY, IRVINE, CA, 92618
- Former names
- SpyGlassPharma, Inc., SpyGlass Ophthalmics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-09 | Khan Bilal Arshad Director | Purchase | +20,000 | $16.00 | $320K | 25,450 |
| 2026-02-09 | Khan Bilal Arshad Director | Purchase | +115,000 | $16.00 | $1.8M | 251,427 |
| 2026-02-09 | Pardo Geoffrey B Director | Conversion | +1,875,013 | 1,875,013 | ||
| 2026-02-09 | Pardo Geoffrey B Director | Purchase | +312,500 | $16.00 | $5.0M | 2,187,513 |
| 2026-02-09 | Pardo Geoffrey B Director | Conversion · Series D Preferred Stock | −1,875,013 | 0 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +2,524,473 | 2,524,473 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +1,806,644 | 1,806,644 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +3,441,966 | $16.00 | $55.1M | 5,966,439 |
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +248,034 | $16.00 | $4.0M | 2,054,678 |
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series C-1 Preferred Stock | −1,150,941 | 0 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series C-1 Preferred Stock | −767,294 | 0 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series C-2 Preferred Stock | −1,150,941 | 0 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series C-2 Preferred Stock | −767,294 | 0 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series D Preferred Stock | −222,591 | 0 | ||
| 2026-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series D Preferred Stock | −272,056 | 0 | ||
| 2026-02-09 | Nielsen Kirk G. Director | Conversion · Series B Preferred Stock | −1,690,230 | 0 | ||
| 2026-02-09 | Nielsen Kirk G. Director | Conversion · Series C-1 Preferred Stock | −548,067 | 0 | ||
| 2026-02-09 | Nielsen Kirk G. Director | Conversion · Series C-2 Preferred Stock | −548,067 | 0 | ||
| 2026-02-09 | Nielsen Kirk G. Director | Conversion · Series D Preferred Stock | −359,255 | 0 | ||
| 2026-02-09 | Behbahani Ali Director | Conversion | +1,619,240 | 1,619,240 |
Page 1 of 9 · 169 trades